Abstract
Bezafibrate belongs to the class of fibric acid derivatives usually used as antihyperlipidemia agents. From the biochemical point of view, these drugs show intriguing properties which leads one to think they may promote a differentiation process in tumour cells. This new pharmacological activity of fibrates could partially depend on the induction of an oxidative stress. To test this hypothesis, the effect of bezafibrate, as well as of clofibric acid and gemfibrozil, on growth, functional and cytochemical characteristics of human leukaemia-derived cell lines HL-60, U-937 and K-562 has been studied in some details. The results show that bezafibrate, gemfibrozil and clofibric acid, do induce differentiation in human myeloid leukaemia cell lines as indicated by several differentiation markers. Moreover fibrates, in dose dependent manner, significantly alter the cell cycle distributions, mainly leading to G0/G1 phase increment and G2/M phase reduction. The differentiating activity of fibrates could have significant implications both for the pharmacotoxicological profile of this class of compounds and for the pathophysiology of neoplastic disease.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Corresponding author
Additional information
Edited by T. Cotter
Rights and permissions
About this article
Cite this article
Scatena, R., Nocca, G., De Sole, P. et al. Bezafibrate as differentiating factor of human myeloid leukemia cells. Cell Death Differ 6, 781–787 (1999). https://doi.org/10.1038/sj.cdd.4400551
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.cdd.4400551
Keywords
This article is cited by
-
Obesity and Leukemia: Biological Mechanisms, Perspectives, and Challenges
Current Obesity Reports (2023)
-
Malonate as a ROS product is associated with pyruvate carboxylase activity in acute myeloid leukaemia cells
Cancer & Metabolism (2016)
-
Normalization of the levels of inflammatory molecules in Mycobacterium smegmatis-infected U937 cells by fibrate pretreatment
Biological Research (2014)
-
Fenofibrate induces effective apoptosis in mantle cell lymphoma by inhibiting the TNFα/NF-κB signaling axis
Leukemia (2010)
-
Fibrates and medroxyprogesterone acetate induce apoptosis of primary Burkitt's lymphoma cells and cell lines: potential for applying old drugs to a new disease
Leukemia (2003)